Deciphera Pharmaceuticals LLC (NASDAQ:DCPH) major shareholder New Leaf Venture Management Ii bought 375,000 shares of Deciphera Pharmaceuticals stock in a transaction on Monday, October 2nd. The shares were acquired at an average price of $17.00 per share, for a total transaction of $6,375,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Shares of Deciphera Pharmaceuticals LLC (DCPH) opened at 20.25 on Thursday. The firm’s 50-day moving average is $19.27 and its 200-day moving average is $19.27. Deciphera Pharmaceuticals LLC has a 12-month low of $16.11 and a 12-month high of $20.87. The firm’s market capitalization is $646.48 million.

TRADEMARK VIOLATION NOTICE: This article was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.watchlistnews.com/insider-buying-deciphera-pharmaceuticals-llc-dcph-major-shareholder-purchases-6375000-00-in-stock/1609023.html.

About Deciphera Pharmaceuticals

Deciphera Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases.

Receive News & Ratings for Deciphera Pharmaceuticals LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deciphera Pharmaceuticals LLC and related companies with Analyst Ratings Network's FREE daily email newsletter.